Adaptive deep brain stimulation in advanced Parkinson disease

Simon Little, Alex Pogosyan, Spencer Neal, Baltazar Zavala, Ludvic Zrinzo, Marwan Hariz, Thomas Foltynie, Patricia Limousin, Keyoumars Ashkan, James FitzGerald, Alexander L Green, Tipu Z Aziz, Peter Brown, Simon Little, Alex Pogosyan, Spencer Neal, Baltazar Zavala, Ludvic Zrinzo, Marwan Hariz, Thomas Foltynie, Patricia Limousin, Keyoumars Ashkan, James FitzGerald, Alexander L Green, Tipu Z Aziz, Peter Brown

Abstract

Objective: Brain-computer interfaces (BCIs) could potentially be used to interact with pathological brain signals to intervene and ameliorate their effects in disease states. Here, we provide proof-of-principle of this approach by using a BCI to interpret pathological brain activity in patients with advanced Parkinson disease (PD) and to use this feedback to control when therapeutic deep brain stimulation (DBS) is delivered. Our goal was to demonstrate that by personalizing and optimizing stimulation in real time, we could improve on both the efficacy and efficiency of conventional continuous DBS.

Methods: We tested BCI-controlled adaptive DBS (aDBS) of the subthalamic nucleus in 8 PD patients. Feedback was provided by processing of the local field potentials recorded directly from the stimulation electrodes. The results were compared to no stimulation, conventional continuous stimulation (cDBS), and random intermittent stimulation. Both unblinded and blinded clinical assessments of motor effect were performed using the Unified Parkinson's Disease Rating Scale.

Results: Motor scores improved by 66% (unblinded) and 50% (blinded) during aDBS, which were 29% (p = 0.03) and 27% (p = 0.005) better than cDBS, respectively. These improvements were achieved with a 56% reduction in stimulation time compared to cDBS, and a corresponding reduction in energy requirements (p < 0.001). aDBS was also more effective than no stimulation and random intermittent stimulation.

Interpretation: BCI-controlled DBS is tractable and can be more efficient and efficacious than conventional continuous neuromodulation for PD.

Copyright © 2013 American Neurological Association.

Figures

Figure 1
Figure 1
Experimental setup for adaptive deep brain stimulation in externalized subjects. Bipolar local field potential (LFP) is passed through a custom built StimRecord amplifier that filters (3–37Hz) and amplifies (×9,100). The analogue (A) output is passed to a 1401 data acquisition unit (Cambridge Electronic Design, Cambridge, UK), which converts it to a digital (D) signal that is displayed on a portable computer using Spike2 software (Cambridge Electronic Design, Cambridge, UK). The signal is digitally filtered around the beta peak in real time and converted to beta amplitude by rectifying and smoothing. A threshold is set that triggers stimulation in a monopolar montage between the 2 bipolar recording electrodes when beta power crosses the threshold. Stimulation terminates when beta power drops again below threshold. [Color figure can be viewed in the online issue, which is available at www.annalsofneurology.org.]
Figure 2
Figure 2
Results in Case 1. (A) Sample section of adaptive deep brain stimulation (aDBS) recordings. Channels are from bottom to top: analogue filtered local field potential (LFP; bipolar contacts 0 and 2), LFP digitally filtered about the beta peak, running average of rectified, beta filtered, amplitude with triggering threshold superimposed, stimulation trigger signal and stimulation (130Hz, 100μS, monopolar contact 1). Boxed area shows a beta burst. Time for this to cross threshold depends on LFP amplitude at onset of beta burst, but thereafter there was only a 30- to 40-millisecond delay to stimulation onset. Note stimulation is ramped, and can be triggered by bursts of beta that are of variable duration, but often last

Figure 3

Clinical improvements. Mean ± standard…

Figure 3

Clinical improvements. Mean ± standard error of the mean percentage change in hemibody…

Figure 3
Clinical improvements. Mean ± standard error of the mean percentage change in hemibody United Parkinson's Disease Rating Scale scores (items 20, 22, and 23) with different stimulation conditions as assessed unblinded during the experimental sessions (A) or from video recordings by blinded experts (B). Asterisks denote significant differences following correction for multiple comparisons by the false discovery rate procedure. All changes were significant from the unstimulated state, with the exception of the blinded score for random stimulation. aDBS = adaptive deep brain stimulation; cDBS = continuous deep brain stimulation.

Figure 4

Decline in triggered stimulation duration…

Figure 4

Decline in triggered stimulation duration over time. Dependency of proportion of time stimulated…

Figure 4
Decline in triggered stimulation duration over time. Dependency of proportion of time stimulated (% per 10-second block) on duration of adaptive deep brain stimulation is shown for Subject 5. Solid and interrupted lines are result of linear regression and 95% confidence intervals, respectively. r = −0.567, p < 0.001.
Figure 3
Figure 3
Clinical improvements. Mean ± standard error of the mean percentage change in hemibody United Parkinson's Disease Rating Scale scores (items 20, 22, and 23) with different stimulation conditions as assessed unblinded during the experimental sessions (A) or from video recordings by blinded experts (B). Asterisks denote significant differences following correction for multiple comparisons by the false discovery rate procedure. All changes were significant from the unstimulated state, with the exception of the blinded score for random stimulation. aDBS = adaptive deep brain stimulation; cDBS = continuous deep brain stimulation.
Figure 4
Figure 4
Decline in triggered stimulation duration over time. Dependency of proportion of time stimulated (% per 10-second block) on duration of adaptive deep brain stimulation is shown for Subject 5. Solid and interrupted lines are result of linear regression and 95% confidence intervals, respectively. r = −0.567, p < 0.001.

References

    1. Hariz M. Twenty-five years of deep brain stimulation: celebrations and apprehensions. Mov Disord. 2012;27:930–933.
    1. Little S, Brown P. What brain signals are suitable for feedback control of deep brain stimulation in Parkinson's disease? Ann N Y Acad Sci. 2012;1265:9–24.
    1. Modolo J, Beuter A, Thomas AW, Legros A. Using “smart stimulators” to treat Parkinson's disease: re-engineering neurostimulation devices. Front Comput Neurosci. 2012;6:69.
    1. Popovych OV, Tass PA. Desynchronizing electrical and sensory coordinated reset neuromodulation. Front Hum Neurosci. 2012;6:58.
    1. Priori A, Foffani G, Rossi L, Marceglia S. Adaptive deep brain stimulation (aDBS) controlled by local field potential oscillations. Exp Neurol. 2013;245:77–86.
    1. Rosin B, Slovik M, Mitelman R, et al. Closed-loop deep brain stimulation is superior in ameliorating parkinsonism. Neuron. 2011;72:370–384.
    1. Abosch A, Lanctin D, Onaran I, et al. Long-term recordings of local field potentials from implanted deep brain stimulation electrodes. Neurosurgery. 2012;71:804–814.
    1. Giannicola G, Rosa M, Servello D, et al. Subthalamic local field potentials after seven-year deep brain stimulation in Parkinson's disease. Exp Neurol. 2012;237:312–317.
    1. Eusebio A, Cagnan H, Brown P. Does suppression of oscillatory synchronisation mediate some of the therapeutic effects of DBS in patients with Parkinson's disease? Front Integr Neurosci. 2012;6:47.
    1. Foltynie T, Hariz MI. Surgical management of Parkinson's disease. Expert Rev Neurother. 2010;10:903–914.
    1. O'Gorman RL, Jarosz JM, Samuel M, et al. CT/MR image fusion in the postoperative assessment of electrodes implanted for deep brain stimulation. Stereotact Funct Neurosurg. 2009;87:205–210.
    1. Eusebio A, Thevathasan W, Doyle Gaynor L, et al. Deep brain stimulation can suppress pathological synchronization in parkinsonian patients. J Neurol Neurosurg Psychiatry. 2011;82:569–573.
    1. Temperli P, Ghika J, Villemure JG, et al. How do parkinsonian signs return after discontinuation of subthalamic DBS? Neurology. 2003;60:78–81.
    1. Lopiano L, Torre E, Benedetti F, et al. Temporal changes in movement time during the switch of the stimulators in Parkinson's disease patients treated by subthalamic nucleus stimulation. Eur Neurol. 2003;50:94–99.
    1. Blahak C, Bäzner H, Capelle HH, et al. Rapid response of parkinsonian tremor to STN-DBS changes: direct modulation of oscillatory basal ganglia activity? Mov Disord. 2009;24:1221–1225.
    1. Ebel RL. Estimation of the reliability of ratings. Psychometrika. 1951;16:407–424.
    1. Blahak C, Capelle HH, Baezner H, et al. Battery lifetime in pallidal deep brain stimulation for dystonia. Eur J Neurol. 2011;18:872–875.
    1. Volkmann J, Herzog J, Kopper F, Deuschl G. Introduction to the programming of deep brain stimulators. Mov Disord. 2002;17:S181–S187.
    1. Benabid AL, Chabardes S, Mitrofanis J, Pollak P. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol. 2009;8:67–81.
    1. Ford B, Winfield L, Pullman S, et al. Subthalamic nucleus stimulation in advanced Parkinson's disease: blinded assessments at one year follow up. J Neurol Neurosurg Psychiatry. 2004;75:1255–1259.
    1. Castrioto A, Lozano AM, Poon Y, et al. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Arch Neurol. 2011;68:1550–1556.
    1. Jenkinson N, Brown P. New insights into the relationship between dopamine, beta oscillations and motor function. Trends Neurosci. 2011;34:611–618.
    1. Hauptmann C, Tass PA. Therapeutic rewiring by means of desynchronizing brain stimulation. Biosystems. 2007;89:173–181.
    1. Afshar P, Khambhati A, Stanslaski S, et al. A translational platform for prototyping closed-loop neuromodulation systems. Front Neural Circuits. 2013;6:117.
    1. Bin-Mahfoodh M, Hamani C, Sime E, Lozano AM. Longevity of batteries in internal pulse generators used for deep brain stimulation. Stereotact Funct Neurosurg. 2003;80:56–60.
    1. Timmermann L, Schüpbach M, Hertel F, et al. A new rechargeable device for deep brain stimulation: a prospective patient satisfaction survey. Eur Neurol. 2013;69:193–199.
    1. Chen CC, Brücke C, Kempf F, et al. Deep brain stimulation of the subthalamic nucleus: a two-edged sword. Curr Biol. 2006;16:952–953.
    1. Brown P, Oliviero A, Mazzone P, et al. Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease. J Neurosci. 2001;21:1033–1038.
    1. Priori A, Foffani G, Pesenti A, et al. Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease. Exp Neurol. 2004;189:369–379.
    1. Alonso-Frech F, Zamarbide I, Alegre M, et al. Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease. Brain. 2006;129:1748–1757.
    1. Kühn AA, Kupsch A, Schneider G, Brown P. Reduction in subthalamic 8-35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease. Eur J Neurosci. 2006;23:1956–1960.
    1. Kühn AA, Tsui A, Aziz T, et al. Pathological synchronisation in the subthalamic nucleus of patients with Parkinson's disease relates to both bradykinesia and rigidity. Exp Neurol. 2009;215:380–387.
    1. Ray NJ, Jenkinson N, Wang S, et al. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation. Exp Neurol. 2008;213:108–113.
    1. Giannicola G, Marceglia S, Rossi L, et al. The effects of levodopa and ongoing deep brain stimulation on subthalamic beta oscillations in Parkinson's disease. Exp Neurol. 2010;226:120–127.
    1. Rosa M, Giannicola G, Servello D, et al. Subthalamic local field beta oscillations during ongoing deep brain stimulation in Parkinson's disease in hyperacute and chronic phases. Neurosignals. 2011;19:151–162.
    1. Brittain JS, Probert-Smith P, Aziz TZ, Brown P. Tremor suppression by rhythmic transcranial current stimulation. Curr Biol. 2013;23:436–440.
    1. Tass PA, Qin L, Hauptmann C, et al. Coordinated reset has sustained aftereffects in Parkinsonian monkeys. Ann Neurol. 2012;72:816–820.

Source: PubMed

3
Abonner